发布求助
文献互助 智能选刊 最新文献

Progress in neuro-psychopharmacology最新文献

筛选
英文 中文
Evaluation of the clinical efficacy of single daily doses of antidepressants 每日单剂量抗抑郁药的临床疗效评价
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90102-8
Domenico De Maio, Mariano Sesso, Alessandro Levi Minzi, Massimo A Caponeri, Carmen Mellado, Michele Bonicalzi
{"title":"Evaluation of the clinical efficacy of single daily doses of antidepressants","authors":"Domenico De Maio,&nbsp;Mariano Sesso,&nbsp;Alessandro Levi Minzi,&nbsp;Massimo A Caponeri,&nbsp;Carmen Mellado,&nbsp;Michele Bonicalzi","doi":"10.1016/0364-7722(81)90102-8","DOIUrl":"10.1016/0364-7722(81)90102-8","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. In the light of the relationship between administration schedule and compliance, comparison data between divided dose regimen and one-time daily dosage of antidepressant drugs are reviewed in terms of therapeutic and pharmacokinetic equivalence.</p></span></li><li><span>2.</span><span><p>2. Divided (b.i.d.) and single (morning) doses of nomifensine (100–200 mg/die) were studied in patients affected with neurotic depression. Clinical results show that the two regimens do not differentiate as for antidepressant eff<span><math><mtext>i</mtext></math></span>cacy and safety.</p></span></li><li><span>3.</span><span><p>3. Nomifensine findings are compared to those obtained with amitriptyline (50–150 mg) given in three different schedules (three daily doses, single dose at morning, single dose at night).</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"4 6","pages":"Pages 607-612"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90102-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18234195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Auto-antibodies in affective disorders 情感性疾病中的自身抗体
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90009-6
Markus Gastpar , Wolfgang Műller
{"title":"Auto-antibodies in affective disorders","authors":"Markus Gastpar ,&nbsp;Wolfgang Műller","doi":"10.1016/0364-7722(81)90009-6","DOIUrl":"10.1016/0364-7722(81)90009-6","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. One hundred depressive patients were tested for the presence of several auto-antibodies.</p></span></li><li><span>2.</span><span><p>2. Rheumatoid factor — tested with three different techniques-, antinuclear antibodies, and two other auto-antibodies (antimitochondrial and anti-basemembrane antibodies) could not be found in a higher frequency than in normals, whereas the occurrence of the thyroglobulin auto-antibodies was just above the upper limit of normals.</p></span></li><li><span>3.</span><span><p>3. Factors eventually influencing the results and directions for further work are discussed on the basis of previous studies.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 1","pages":"Pages 91-97"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90009-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18022488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Psychophysiology of anxiety, fear and phobia 焦虑、恐惧和恐惧症的心理生理学
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90066-7
Hans Heimann, Henner Giedke
{"title":"Psychophysiology of anxiety, fear and phobia","authors":"Hans Heimann,&nbsp;Henner Giedke","doi":"10.1016/0364-7722(81)90066-7","DOIUrl":"10.1016/0364-7722(81)90066-7","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. First, the authors present a brief outline of the concepts of anxiety, fear and phobia and their physiological concomitants.</p></span></li><li><span>2.</span><span><p>2. Experimental findings are then presented showing that the emotional state of anxiety is generally linked to physiological activation as measured in spontaneous fluctuations and habituation rate of the orienting response of the galvanic skin response (GSR).</p></span></li><li><span>3.</span><span><p>3. Other findings show that on the contrary, depression is linked to inhibition or disactivation of these systems, and also of contingent negative variations (CNV).</p></span></li><li><span>4.</span><span><p>4. In unselected samples of anxious-depressed patients, the above relationships do not become obvious when psychopathology is self-rated, which suggests that anxiety and depression are better distinguished by the examining physician than by the patients themselves.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 2","pages":"Pages 167-177"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90066-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18070590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis 氯丙帕明与阿米替林治疗强迫神经症的双盲比较研究
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90077-1
Jambur Ananth , John C. Pecknold , Nancy Van Den Steen , Frank Engelsmann
{"title":"Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis","authors":"Jambur Ananth ,&nbsp;John C. Pecknold ,&nbsp;Nancy Van Den Steen ,&nbsp;Frank Engelsmann","doi":"10.1016/0364-7722(81)90077-1","DOIUrl":"10.1016/0364-7722(81)90077-1","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. The efficacy of clomipramine hydrochloride in severe obsessive compulsive neurosis (OCN) was compared with that of amitriptyline in a four week randomized double-blind trial.</p></span></li><li><span>2.</span><span><p>2. Clomipramine but not amitriptyline produced statistically significant improvement in the obsessive symptoms, depression and anxiety.</p></span></li><li><span>3.</span><span><p>3. The lack of significant effect of amitriptyline on anxiety and depression may be due to its inability to improve the primary obsessive symptoms.</p></span></li><li><span>4.</span><span><p>4. No serious adverse effects were encountered in either drug group.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 3","pages":"Pages 257-262"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90077-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18070593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 137
Effects of psychotropic drugs on hamster hibernation—pilot study 精神药物对仓鼠冬眠影响的初步研究
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90055-2
Peter Zvolsky , Libor Jansky , Jana Vyskocilova , Paul Grof
{"title":"Effects of psychotropic drugs on hamster hibernation—pilot study","authors":"Peter Zvolsky ,&nbsp;Libor Jansky ,&nbsp;Jana Vyskocilova ,&nbsp;Paul Grof","doi":"10.1016/0364-7722(81)90055-2","DOIUrl":"10.1016/0364-7722(81)90055-2","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. The desynchronization of circadian and circannual rhythms may play an important role in primary affective disorders.</p></span></li><li><span>2.</span><span><p>2. Interesting biochemical as well as anatomical parallels have been found between primary affective disorders and hibernation.</p></span></li><li><span>3.</span><span><p>3. Hibernation is a periodic circannual event which is determined mainly by internal and hereditary factors, and influenced also by environmental stimuli. We employed hibernation as an animal model of periodic events and studied the effect of psychotropic drugs on hibernation in the golden hamster.</p></span></li><li><span>4.</span><span><p>4. In this paradigm imipramine clearly interfered with the hibernating process and caused significant prolongation of the prehibernation period. The results of lithium trial could not be interpreted because of methodological problems.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 5","pages":"Pages 599-602"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90055-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18215413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Psychopharmacology for the elderly 老年人精神药理学
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90084-9
William M. Petrie, Thomas A. Ban
{"title":"Psychopharmacology for the elderly","authors":"William M. Petrie,&nbsp;Thomas A. Ban","doi":"10.1016/0364-7722(81)90084-9","DOIUrl":"10.1016/0364-7722(81)90084-9","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. The use of tricyclic antidepressant agents in the elderly is limited by their anticholinergic and cardiovascular action. Newer compounds, such as mianserin, maprotiline and trazadone may provide advantages in this respect.</p></span></li><li><span>2.</span><span><p>2. In the control of agitation and/or psychosis antipsychotic and <em>β</em>-blockers have been successfully employed.</p></span></li><li><span>3.</span><span><p>3. Cerebral vasodilators, metabolic enhancers, and neuropeptides have been studied but their place in the treatment of psychogeriatric patients has not been clearly established.</p></span></li><li><span>4.</span><span><p>4. Dihydroergotoxine has been extensively documented as providing significant benefit to patients with senile dementia of the Alzheimer type.</p></span></li><li><span>5.</span><span><p>5. The cholinergic system may serve important functions in memory, although findings about the therapeutic effect of cholinergic agents are consistent.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 4","pages":"Pages 335-342"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90084-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17186518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Propranolol (inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: Possible involvement of beat - adrenergic mechanisms 心得安治疗迟发性运动障碍和抗精神病药的锥体外系副作用:可能与肾上腺素能机制有关
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90105-3
Robert Wilbur , Frank A Kulik
{"title":"Propranolol (inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: Possible involvement of beat - adrenergic mechanisms","authors":"Robert Wilbur ,&nbsp;Frank A Kulik","doi":"10.1016/0364-7722(81)90105-3","DOIUrl":"10.1016/0364-7722(81)90105-3","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. This clinical report describes four psychotic patients with neuroleptic-induced tardive (orofacial) dyskinesia and extrapyramidal side effects who were successfully treated with propranolol 30 – 60 mg per day.</p></span></li><li><span>2.</span><span><p>2. Relief of orofacial symptoms and tremor was marked and rapid (one to ten days). In one case propranolol was stopped and orofacial symptoms emerged.</p></span></li><li><span>3.</span><span><p>3. No side effects were observed.</p></span></li><li><span>4.</span><span><p>4. The literature on propranolol in tardive dyskinesia and tremor disorders is reviewed. Central and peripheral mechanisms are considered, and several specific experiments are proposed to clarify the site of action. It is suggested that clinical investigation with propranolol in tardive dyskinesia and extrapyramidal side effects might enhance our understanding of the possible adrenergic modulation of the dopaminergic/cholinergic balance in the striatum.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"4 6","pages":"Pages 627-632"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90105-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17178016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Antianxiety agents and emotional behavior: An information processing analysis 抗焦虑剂与情绪行为:一项信息加工分析
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90074-6
Michael D. Morris, Gerald F. Gebhart
{"title":"Antianxiety agents and emotional behavior: An information processing analysis","authors":"Michael D. Morris,&nbsp;Gerald F. Gebhart","doi":"10.1016/0364-7722(81)90074-6","DOIUrl":"10.1016/0364-7722(81)90074-6","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. Various paradigms which are considered to produce and measure fear, anxiety, frustration and aggression in non-human animals are briefly reviewed.</p></span></li><li><span>2.</span><span><p>2. The efficacy of antianxiety drugs in these paradigms is discussed. It is clear that the tasks investigators have devised to measure emotion may be measuring several effects of antianxiety drugs.</p></span></li><li><span>3.</span><span><p>3. An information processing model is proposed therefore, to bring about a clearer understanding of the effects of antianxiety agents on human and non-human animals.</p></span></li><li><span>4.</span><span><p>4. Among the five stages of information processing considered, the stimulus selection, response selection and response inhibition stages are considered important to understanding antianxiety drug effects.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 3","pages":"Pages 219-240"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90074-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17182688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Drug induced dementia 药物性痴呆
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90097-7
Jan Libiger, Thomas A Ban
{"title":"Drug induced dementia","authors":"Jan Libiger,&nbsp;Thomas A Ban","doi":"10.1016/0364-7722(81)90097-7","DOIUrl":"10.1016/0364-7722(81)90097-7","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. Pharmacological agents with a potential to induce dementia are reviewed with special reference to anxiolytic sedatives, anticonvulsants, antineoplastic drugs and various metals.</p></span></li><li><span>2.</span><span><p>2. The possible role of cholinergic mechanisms, tetrahydrofolate deficiency and aluminum in the development of dementia is briefly discussed.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"4 6","pages":"Pages 561-567"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90097-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17178015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Electroencephalographic signs of anxiety 焦虑的脑电图迹象
Progress in neuro-psychopharmacology Pub Date : 1981-01-01 DOI: 10.1016/0364-7722(81)90068-0
Werner P. Koella
{"title":"Electroencephalographic signs of anxiety","authors":"Werner P. Koella","doi":"10.1016/0364-7722(81)90068-0","DOIUrl":"10.1016/0364-7722(81)90068-0","url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. Among the many objective symptoms or concomitants of anxiety electroencephalographic signs are of particular interest, as they are liable to detect “abnormalities” in the functioning of the brain and thus are likely to help our understanding of the pathogenesis of this disorder.</p></span></li><li><span>2.</span><span><p>2. A low output in the <em>α</em>-band, a poor <em>α</em>-organization, impaired “driving” within the <em>α</em>-frequencies by stroboscopic stimulation and a reduced amplitude of the contingent negative variation seem to constitute the most typical electroencephalographic symptoms.</p></span></li><li><span>3.</span><span><p>3. These various signs clearly indicate a disbalance in the activity and reactivity in those neuronal systems that control the level of general and discrete vigilance.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 2","pages":"Pages 187-192"},"PeriodicalIF":0.0,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90068-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18070592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信